Eric Perreault is the founder of KIYATEC. KIYATEC has raised $26M in total funding. Latest round: Series C.
Eric Perreault is the Chief Executive Officer of KIYATEC, a company that provides solutions to patients, oncologists, and pharmaceutical companies in their cancer therapy decisions. KIYATEC develops 3D cell culture platforms using patients' live tumor tissue to predict responses to cancer therapies before treatment, enabling personalized medicine. Eric has 30 years of experience in medical sales and marketing, with a focus on diagnostics.
Full founder directory · Investor directory · Company funding database · Fundraising library